Status:
UNKNOWN
Glucocorticoids and Pulmonary Hypertension
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Pulmonary Hypertension
Eligibility:
All Genders
1-5 years
Brief Summary
Pediatric idiopathic pulmonary hypertension has significant morbidity and mortality. An ever expanding body of knowledge indicates the important contribution of inflammation to pathogenesis and succes...
Eligibility Criteria
Inclusion
- premature, BPD, \>36 wga
- pulmonary hypertension evidence by echocardiogram
Exclusion
- poor ventilation/oxygenation
Key Trial Info
Start Date :
July 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 29 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04499196
Start Date
July 29 2020
End Date
July 29 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Louis Children's Hospital
St Louis, Missouri, United States, 63110